Corline Biomedical (Sweden) Analysis
| CLBIO Stock | SEK 6.42 0.18 2.73% |
Corline Biomedical AB is overvalued with Real Value of 6.02 and Hype Value of 6.42. The main objective of Corline Biomedical stock analysis is to determine its intrinsic value, which is an estimate of what Corline Biomedical AB is worth, separate from its market price. There are two main types of Corline Biomedical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Corline Biomedical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Corline Biomedical's stock to identify patterns and trends that may indicate its future price movements.
The Corline Biomedical stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Corline Biomedical is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Corline Stock trading window is adjusted to Europe/Stockholm timezone.
Corline |
Corline Stock Analysis Notes
About 55.0% of the company shares are held by company insiders. The book value of Corline Biomedical was currently reported as 4.38. The company had not issued any dividends in recent years. Corline Biomedical had 1196:1163 split on the 4th of January 2021. Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. The company was founded in 1991 and is based in Uppsala, Sweden. Corline Biomedical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 9 people. For more info on Corline Biomedical AB please contact the company at 46 18 71 30 90 or go to https://www.corline.se.Corline Biomedical Investment Alerts
| Corline Biomedical generated a negative expected return over the last 90 days | |
| Corline Biomedical has high historical volatility and very poor performance | |
| Corline Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.06 M. Net Loss for the year was (6.92 M) with profit before overhead, payroll, taxes, and interest of 9.1 M. | |
| Corline Biomedical AB has accumulated about 41.63 M in cash with (4.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. | |
| Roughly 55.0% of the company shares are held by company insiders |
Corline Biomedical Thematic Classifications
In addition to having Corline Biomedical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | DrugsDrug manufacturing and delivery |
Corline Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 203.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Corline Biomedical's market, we take the total number of its shares issued and multiply it by Corline Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Corline Profitablity
Corline Biomedical's profitability indicators refer to fundamental financial ratios that showcase Corline Biomedical's ability to generate income relative to its revenue or operating costs. If, let's say, Corline Biomedical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Corline Biomedical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Corline Biomedical's profitability requires more research than a typical breakdown of Corline Biomedical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Technical Drivers
As of the 23rd of November, Corline Biomedical shows the Standard Deviation of 3.93, risk adjusted performance of (0.10), and Mean Deviation of 2.87. Corline Biomedical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Corline Biomedical information ratio and potential upside to decide if Corline Biomedical is priced correctly, providing market reflects its regular price of 6.42 per share.Corline Biomedical Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Corline Biomedical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Corline Biomedical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Corline Biomedical Outstanding Bonds
Corline Biomedical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Corline Biomedical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Corline bonds can be classified according to their maturity, which is the date when Corline Biomedical AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Corline Biomedical Predictive Daily Indicators
Corline Biomedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Corline Biomedical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Corline Biomedical Forecast Models
Corline Biomedical's time-series forecasting models are one of many Corline Biomedical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Corline Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Corline Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Corline Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Corline shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Corline Biomedical. By using and applying Corline Stock analysis, traders can create a robust methodology for identifying Corline entry and exit points for their positions.
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. The company was founded in 1991 and is based in Uppsala, Sweden. Corline Biomedical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 9 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Corline Biomedical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for Corline Stock Analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.